Navigation Links
Prostate Cancer Therapeutics Market Worth $8.0 billion by 2019
Date:11/19/2013

DALLAS, Nov. 19, 2013 /PRNewswire-iReach/ -- The recent approval of a number of highly effective drugs, including Zytiga and Xtandi, has provided late-stage patients with a number of options and increased survival times by a number of months. These recent approvals are anticipated to generate strong revenues during the forecast following increasing uptake by physicians as the treatment algorithm shifts towards their first-line usage over Taxotere. Additionally, a very large late-stage pipeline is anticipated to produce a number of new market entrants which are superior to existing products. Overall, this is anticipated to drive rapid market growth from $4.1 billion in 2012 to $8.0 billion by 2019 at a CAGR of 10.1%.

(Photo: http://photos.prnewswire.com/prnh/20131119/MN19794)

Scope

  • A brief introduction to prostate cancer, including the disease's pathogenesis, risk factors, diagnosis, staging and treatment algorithms for each stage.
  • In-depth analysis of drugs available for the treatment of prostate cancer, including analyses of their safety, efficacy, treatment patterns and strengths/weaknesses. Includes a heat map comparing the drugs in terms of safety and efficacy.
  • Comprehensive review of the pipeline for prostate cancer therapies, including individual analysis of a number of late-stage pipeline drugs that are likely to enter the market in the forecast period. The pipeline is analyzed on the basis of phase distribution, molecule types and molecular targets, program type.
  • Additional in-depth analysis of pipeline drug clinical trials by phase, molecule type, trial size, trial duration and program failure rate analyses for each molecule type and mechanism of action.
  • Multi-scenario forecast data of the market to 2019, taking into account how it will be affected by the in
    '/>"/>

SOURCE RnR Market Research
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. New Veridex Alliance Drives Study Of Circulating Tumor Cells In Men With Metastatic Prostate Cancer
2. Accuray Launches First Study to Compare CyberKnife® SBRT to Surgery and IMRT for Treatment of Early-Stage Prostate Cancer
3. Debiopharm and Vifor Pharma Sign an Exclusive Agreement for the Distribution and Commercialization of Pamorelin®LA in Switzerland - A Drug Treatment for Prostate Cancer and Endometriosis
4. US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
5. Ventana licenses Gen-Probe IP for measuring ERG protein in prostate cancer patients
6. CyberKnife® Prostate SBRT Outcomes and Quality of Life Data Presented at American Urological Association Meeting
7. Arkansas Prostate Cancer Center Earns High Honor of ACR-ASTRO Accreditation
8. Breakthrough Prostate Cancer Diagnostics
9. New Research Reveals Some Natural Supplements Effective Against Prostate Cancer
10. Prostate Cancer and Bone Health
11. New Legislation To Make USPSTF More Transparent: Prostate Cancer Roundtable Supports Reform
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... July 29, 2015  Cepheid (Nasdaq: CPHD ... update to Xpert® Carba-R, with the addition of ... The on-demand, molecular test also detects and differentiates ... resistance, namely KPC, NDM, VIM, IMP-1 and OXA-48. ... CROs or Superbugs, are a growing and expensive ...
(Date:7/29/2015)... HERTFORDSHIRE, England and PITTSBURGH ... MYL ) today announced that it received regulatory clearance ... Regulation (EUMR) for its proposed acquisition of Perrigo Company ... Mylan,s Executive Chairman Robert J. Coury commented, ... of completing our acquisition of Perrigo and serves as ...
(Date:7/29/2015)... VIEW, Calif. , July 29, 2015  Efforts ... the growth strategy of pharmaceutical firms in ... . The realization is that an effective working capital ... pricing pressures and patent cliffs. Big pharma companies expect ... returns. Logo - http://photos.prnewswire.com/prnh/20150724/241957LOGO ...
Breaking Medicine Technology:'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 2'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 3'Superbug' Test Updated to Identify Newest Carbapenem-Resistant Organisms 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 2Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 3Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 4Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 5Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 6Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 7Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 8Mylan Announces Receipt of Unconditional Clearance from European Commission on Acquisition of Perrigo 9Working Capital Management Seizes Priority in North American and European Pharma Industry 2Working Capital Management Seizes Priority in North American and European Pharma Industry 3Working Capital Management Seizes Priority in North American and European Pharma Industry 4
... and Pipeline Analysis, 4th Edition Now Available... -- DALLAS, September 28, 2010 ... ... --> ... = ,; var first_result; // Results are keyed by longUrl, so we need to grab the first ...
... SCOLR Pharma, Inc. (NYSE AMEX: DDD ... as the Chairman of its Board of Directors.  Johnson ... the Board.   Johnson previously served as ... Under Johnson,s leadership, Matrixx successfully developed and launched the ...
Cached Medicine Technology:Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 2Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 3Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 4Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 5Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 6Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 7Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 8Emerging Cancer Vaccines Market: Forecasts, Developments and Pipeline Analysis, 4th Edition Now Available at ReportsandReports 9SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 2SCOLR Pharma, Inc. Names Carl Johnson as Chairman; Former Chairman Michael Taglich Remains as Director 3
(Date:7/29/2015)... Rhinebeck, NY (PRWEB) , ... July 29, 2015 ... ... 555 Fitness as a sponsor, with its Topricin® Pain Relief and Healing Cream ... is a firefighter-founded web-based organization that is actively addressing Line of Duty Deaths ...
(Date:7/29/2015)... Jacksonville, Fla. (PRWEB) , ... July 29, 2015 , ... ... due to record-setting precipitation levels this spring. And, where there is water, mold is ... and commercial property, offers tips for protecting against water and mold damage. Paul Davis ...
(Date:7/29/2015)... ... 29, 2015 , ... CrossFit 269, offering a nationally franchised ... Strength & Conditioning. , The name change coincides with the release of its ... center over the past three years,” according to Jack Kelly, the center’s owner ...
(Date:7/29/2015)... ... July 29, 2015 , ... Orthopedic surgeons at Lourdes Medical ... Rotation Medical Rotator Cuff System, a new implant to treat a common source of ... foster natural regeneration of additional tendon tissue, which could allow for faster healing and ...
(Date:7/29/2015)... ... ... in full swing, which means bridal beauty prep is officially in overdrive. With the excitement ... bride wants to look and feel beautiful, but a recent study suggests that brides-to-be are ... by the American Academy of Facial Plastic and Reconstructive Surgery (AAFPRS) , reveals ...
Breaking Medicine News(10 mins):Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 2Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 3Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 4Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 5Health News:Topical BioMedics Partners with 555 Fitness: Topricin® Designated as the Nonprofit’s Natural Pain Reliever of Choice 6Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 2Health News:Paul Davis Offers Tips to Minimize Property Damage and Health Risks This Flood Season 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 2Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 3Health News:Kalamazoo’s CrossFit 269 Changes Name, Opens New Website 4Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 2Health News:Lourdes Orthopedics First in NJ to Offer Bioinductive Implant for Rotator Cuff Repair 3Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 2Health News:Say I Do To Surgery: Bridal Beauty On The Rise According to New Survey 3
... finds too few people meet fruit and veggie guidelines , ... the recommended amounts of fruits and vegetables, says a U.S. ... objectives for consumption of fruits and vegetables, it found. , ... get at least 75 percent of Americans to eat the ...
... unprecedented statewide collaboration for breast cancer patients with the ... designing and testing new approaches to research, technology and ... Network, the groundbreaking project will initially involve 150,000 women ... and followed for decades through the five UC medical ...
... of national recommendations, study finds, , TUESDAY, Sept. 29 (HealthDay ... one-third of Americans know about national recommendations for a minimum ... half meet that goal, a new study has found. , ... and people born in the United States, the researchers said. ...
... in French . , MONTREAL, 29 September ... in American prisons than in the general population. Adherence to ... prisoners are released, medical monitoring becomes problematic. A new study ... Medicine and a medical scientist at the Research Institute of ...
... weighing swine flu school closures should review past practices, ... -- An analysis of disease control measures used during ... the issue of school closures this fall in response ... , Last spring, school closures were a common and ...
... , ... the latest report in its series on emerging markets of clinical research, China: A New ... ... pharma industry are beginning to drive growth and reforms that are stimulating a new drug ...
Cached Medicine News:Health News:Eating in America Still Unhealthy: CDC 2Health News:Eating in America Still Unhealthy: CDC 3Health News:Revolutionary statewide UC collaboration targets breast cancer 2Health News:Revolutionary statewide UC collaboration targets breast cancer 3Health News:Revolutionary statewide UC collaboration targets breast cancer 4Health News:Revolutionary statewide UC collaboration targets breast cancer 5Health News:Exercise 30 Minutes a Day? Who Knew! 2Health News:Study highlights HIV/AIDS challenge in American prison system 2Health News:1918 Flu Closings May Provide Lessons for Today 2Health News:Innovation and Global Clinical Trial Participation are the Focus of CenterWatch's Latest Special Report on China's Drug Development Industry 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: